Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation.
Xing ChenChunyu YuXinhua LiuBeibei LiuXiaodi WuJiajing WuDong YanLulu HanZifan TangXinyi YuanJian-Qiu WangYue WangShumeng LiuLin ShanYongfeng ShangPublished in: Nature communications (2022)
How the carbohydrate binding protein galectin-3 might act as a diabetogenic and tumorogenic factor remains to be investigated. Here we report that intracellular galectin-3 interacts with Rag GTPases and Ragulator on lysosomes. We show that galectin-3 senses lipopolysaccharide (LPS) to facilitate the interaction of Rag GTPases and Ragulator, leading to the activation of mTORC1. We find that the lipopolysaccharide/galectin-3-Rag GTPases/Ragulator-mTORC1 axis regulates a cohort of genes including GLUT1, and HK2, and PKM2 that are critically involved in glucose uptake and glycolysis. Indeed, galectin-3 deficiency severely compromises LPS-promoted glycolysis. Importantly, the expression of HK2 is significantly reduced in diabetes patients. In multiple types of cancer including hepatocellular carcinoma (HCC), galectin-3 is highly expressed, and its level of expression is positively correlated with that of HK2 and PKM2 and negatively correlated with the prognosis of HCC patients. Our study unravels that galectin-3 is a sensor of LPS, an important modulator of the mTORC1 signaling, and a critical regulator of glucose metabolism.
Keyphrases
- inflammatory response
- binding protein
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- toll like receptor
- poor prognosis
- type diabetes
- lps induced
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- anti inflammatory
- transcription factor
- metabolic syndrome
- gene expression
- genome wide
- reactive oxygen species
- mass spectrometry
- skeletal muscle
- lymph node metastasis
- replacement therapy